Tick-Borne Disease Working Group Special Issue SECTION

The Undercounting of Lyme Disease

Tick-Borne Disease Working Group Special Issue

The Undercounting of Lyme Disease

We need accurate data about ticks, the infections they carry, and the number of tick-borne disease cases in all parts of the country.

By Phyllis Mervine

Why We Care About the Safety and Efficacy of Lyme Disease Vaccines

Tick-Borne Disease Working Group Special Issue

Why We Care About the Safety and Efficacy of Lyme Disease Vaccines

You don’t have to be an “anti-vaxxer” in order to raise questions about Lyme disease vaccines.

By Phyllis Mervine

How the LYMErix Lyme Disease Vaccine was Pulled from the Market

Tick-Borne Disease Working Group Special Issue

How the LYMErix Lyme Disease Vaccine was Pulled from the Market

Patricia Smith, president of LDA, identifies lessons we can learn from the LYMErix Lyme disease vaccine story and pitfalls we can hopefully avoid in the future.

By Pat Smith

Minority Opinion Is a Critical Element of the Tick-Borne Disease Working Group Report

Tick-Borne Disease Working Group Special Issue

Minority Opinion Is a Critical Element of the Tick-Borne Disease Working Group Report

A summary of how minority opinions influenced the Tick-Borne Disease Working Groups views on vaccines, treatment, and diagnosising Lyme disease.

By Phyllis Mervine

Most Popular Articles

NEWSLETTER SIGN UP

Subscribe to our mailing list and get Lyme disease news updates to your email inbox.

[gravityform id=1 title=false description=false ajax=true tabindex=49]

We respect your privacy and take protecting it seriously.